Company Profile

CiceroDx Inc (AKA: Cicero Diagnostics)
Profile last edited on: 9/26/22      CAGE: 81KR0      UEI: D37XGZLKKLJ9

Business Identifier: Advancement of clinical assays for understudied diseases
Year Founded
----
First Award
2019
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5075 Warner Avenue Suite 202
Huntington Beach, CA 92649
   (714) 475-1533
   N/A
   www.cicerodx.com
Location: Single
Congr. District: 48
County: Orange

Public Profile

Cicerodx Inc (aka Cicero Diagnostics) is a diagnostics company structured around developing clinical assays for understudied diseases. A primary focus of current CiceroDx efforts is endometriosis - a disease affecting millions of women who - because diagnosis can take many years - can endure years of pain, infertility and bowel or bladder symptoms without knowing endometriosis to be the cause. As the exclusive licensed provider for BCL6 analysis on endometrial tissue, Circerodix Inc. is tackling enabling both healthcare professionals and their patients better to understand how these new testing modalities can impact treatments and long term outcomes

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 2 NIH $1,126,084
Project Title: SIRT1 and BCL6: Dual Biomarkers of Endometriosis and Endometrial Receptivity

Key People / Management

  Christopher Jackson -- CEO and President

  Dan Angress -- COO

  Kendall Dieterle -- Manager – Client Relations

  Allen M Gown -- Founder & Chief Pathologist, PhenoPath

  Bruce Lessey -- Scientific Advisor

  David Schammel -- Pathologist and Partner at Pathology Associates

Company News

There are no news available.